Monoamine oxidase inhibitor

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from MAOI)
Jump to: navigation, search

Monoamine oxidase inhibitors, also called MAOIs or MAO inhibitors, are a class of antidepressants.[1] They were the first antidepressants to be developed.[1] Though effective, they have been replaced as a first-line treatment following the development of other antidepressants posing fewer safety and side effect issues.[1] Use of MAOIs typically involves dietary restrictions owing to dangerous side effects that can result from interactions with some foods.[1] Nevertheless, MAOIs can still be a good treatment option for depression, especially in cases where other antidepressants have been ineffective.[1]

As of June 2016, the FDA has approved the following MAOIs to treat depression:

References[edit | edit source]

  1. 1.01.11.21.31.4 "Monoamine oxidase inhibitors (MAOIs)". Mayo Clinic. Retrieved Jan 8, 2019. 

adverse reaction - Any unintended or unwanted response to the treatment under investigation in a clinical trial.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.